Startups
SpyGlass Ophthalmics
Edit

SpyGlass Ophthalmics

http://www.spyglassophthalmics.com/
Last activity: 21.07.2021
Active
Categories: HardwareLifeMedTech
A vision towards a higher quality of life!
Mentions
8

Overview

Employees
11-50
Total raised
$27.5M
Founded date
2019

Investors 1

DateNameWebsite
Sign up to seeSign up to seeSign up to see

Funding Rounds 1

DateSeriesAmountInvestors
Sign up to seeSign up to seeSign up to seeSign up to see

Mentions in press and media 8

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Jan 11, 2021SpyGlass Ophthalmics Closes $27.5M in Series B FinancingSpyGlass Ophthalmics, a Mission Viejo, CA-based ophthalmic therapeutics company, secured $27.5m in Series B financing. The round was led by Vensana Capital with participation from existing investor New Enterprise Associates. In conjunction ...
Jan 11, 2021NEA Joins $27.5M Series B for SpyGlass OphthalmicsSpyGlass Ophthalmics, a Mission Viejo, CA-based ophthalmic therapeutics company, secured $27.5m in Series B financing. The round was led by Vensana Capital with participation from existing investor New Enterprise Associates. In conjunction ...
Jan 11, 2021NEA Joins $27.5M Series B for SpyGlass OphthalmicsSpyGlass Ophthalmics, a Mission Viejo, CA-based ophthalmic therapeutics company, secured $27.5m in Series B financing. The round was led by Vensana Capital with participation from existing investor New Enterprise Associates. In conjunction ...
Jan 9, 2021Startup Funding News for the Day – Medtech SectorThese are a few US-based startups that raised funding today:
Jan 8, 2021SpyGlass Ophthalmics Snares $27.5M Series B MISSION VIEJO, CA, SpyGlass Ophthalmics has secured $27.5 million in Series B financing led by Vensana Capital. >> Click here for more funding data on SpyGlass Ophthalmics >> To export SpyGlass Ophthalmics funding data to PD...
Jan 7, 2021SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic DiseasesMISSION VIEJO, Calif. (PRWEB) January 07, 2021 SpyGlass Ophthalmics (“SpyGlass”), a privately-held ophthalmic therapeutics company announced today that it has secured $27.5 million in Series B financing. The financing, which was led by Vens...
Spyglass Ophthalmics“A vision towards a higher quality of life!”

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about SpyGlass Ophthalmics

When was SpyGlass Ophthalmics founded?

SpyGlass Ophthalmics was founded in 2019.

How much funding has SpyGlass Ophthalmics raised?

SpyGlass Ophthalmics has raised $27.5M in total across 1 funding round.

What has the press written about SpyGlass Ophthalmics?

Parsers VC has collected 8 articles mentioning SpyGlass Ophthalmics, among them “SpyGlass Ophthalmics Closes $27.5M in Series B Financing” (Jan 11, 2021) and “NEA Joins $27.5M Series B for SpyGlass Ophthalmics” (Jan 11, 2021).

Is SpyGlass Ophthalmics still active?

Yes, SpyGlass Ophthalmics is active; its latest activity on Parsers VC dates from Jul 21, 2021.